Cargando…
Effect of Urinary Protease Inhibitor (Ulinastatin) on Cardiopulmonary Bypass: A Meta-Analysis for China and Japan
OBJECTIVES: A meta-analysis was conducted to investigate the effects of ulinastatin treatment on adult patients undergoing cardiac surgery under cardiopulmonary bypass (CPB). METHODS: Seven electronic databases were searched for reports of randomized, controlled trials conducted up to February 2014...
Autores principales: | Zhang, Yun, Zeng, Zhi, Cao, Yu, Du, Xiaodong, Wan, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263539/ https://www.ncbi.nlm.nih.gov/pubmed/25500819 http://dx.doi.org/10.1371/journal.pone.0113973 |
Ejemplares similares
-
Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
por: Qiu, Yan, et al.
Publicado: (2015) -
Effects of Ulinastatin on Postoperative Blood Loss and Hemostasis in Atrioventricular Valve Surgery with Cardiopulmonary Bypass
por: Park, Jae Bum, et al.
Publicado: (2013) -
The effect of Ulinastatin on postoperative course in cardiopulmonary bypass patients in Asia: a meta-analysis of randomized controlled trials
por: Zhenyu, Hu, et al.
Publicado: (2022) -
Effects of ulinastatin treatment on myocardial and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass
por: Oh, Se-young, et al.
Publicado: (2012) -
Effect of Urinary Trypsin Inhibitor (Ulinastatin) Therapy in COVID-19
por: Jain, Ashish, et al.
Publicado: (2022)